Thomas Strack

1.0k total citations
56 papers, 760 citations indexed

About

Thomas Strack is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Thomas Strack has authored 56 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Surgery. Recurrent topics in Thomas Strack's work include Diabetes Management and Research (21 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Diabetes Treatment and Management (9 papers). Thomas Strack is often cited by papers focused on Diabetes Management and Research (21 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Diabetes Treatment and Management (9 papers). Thomas Strack collaborates with scholars based in United States, Canada and Germany. Thomas Strack's co-authors include Bernard Zinman, Hugh D. Tildesley, Jean‐Louis Chiasson, Elaine Y. L. Tsui, Nick Freemantle, R V Campos, S. Ross, Nancy Stambler, Vivien Wong and Bernard Zinman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Thomas Strack

54 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Strack United States 13 451 257 178 125 97 56 760
Hélène Dulude Canada 16 326 0.7× 160 0.6× 160 0.9× 184 1.5× 17 0.2× 37 798
Yuh‐Seog Jung South Korea 15 224 0.5× 225 0.9× 66 0.4× 63 0.5× 44 0.5× 48 696
Öyvind Östraat Sweden 10 183 0.4× 559 2.2× 227 1.3× 107 0.9× 21 0.2× 23 763
Alessandra Martorella United States 8 238 0.5× 168 0.7× 50 0.3× 36 0.3× 45 0.5× 11 512
Nima Almassi United States 17 142 0.3× 284 1.1× 80 0.4× 358 2.9× 52 0.5× 77 857
Jeff M. Holzbeierlein United States 6 120 0.3× 344 1.3× 91 0.5× 364 2.9× 48 0.5× 7 963
H. J. de Voogt Netherlands 18 277 0.6× 371 1.4× 100 0.6× 605 4.8× 49 0.5× 51 1.2k
Halil Kavgacı Türkiye 14 86 0.2× 96 0.4× 33 0.2× 106 0.8× 97 1.0× 55 623
David Paulson United States 10 75 0.2× 266 1.0× 29 0.2× 122 1.0× 49 0.5× 26 632
Katsumi Taki Japan 9 333 0.7× 43 0.2× 105 0.6× 35 0.3× 68 0.7× 14 660

Countries citing papers authored by Thomas Strack

Since Specialization
Citations

This map shows the geographic impact of Thomas Strack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Strack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Strack more than expected).

Fields of papers citing papers by Thomas Strack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Strack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Strack. The network helps show where Thomas Strack may publish in the future.

Co-authorship network of co-authors of Thomas Strack

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Strack. A scholar is included among the top collaborators of Thomas Strack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Strack. Thomas Strack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wainberg, Zev A., Monica Mita, Minal Barve, et al.. (2021). A phase I open-label study to investigate safety and tolerability, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of MT-5111 in patients with HER2-positive tumors.. Journal of Clinical Oncology. 39(3_suppl). TPS258–TPS258. 1 indexed citations
2.
Wainberg, Zev A., Minal Barve, Erika Hamilton, et al.. (2020). A phase I study of the novel immunotoxin, MT-5111, in subjects (subj) with HER-2 positive tumors: Interim results.. Journal of Clinical Oncology. 38(15_suppl). e15567–e15567. 2 indexed citations
3.
4.
Leifke, Eckhard & Thomas Strack. (2014). Subcutaneous insulin therapy - end of the road after 80 years?. Drugs of today. 50(2). 181–181. 3 indexed citations
5.
Marcinak, John, Prabhakar Viswanathan, Vipin Arora, et al.. (2011). Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs. Clinical Pharmacology & Therapeutics. 91(3). 514–520. 4 indexed citations
6.
Hompesch, Marcus, Alexa P. Kollmeier, Klaus Rave, et al.. (2009). Glycemic Exposure Is Affected Favorably by Inhaled Human Insulin (Exubera) as Compared with Subcutaneous Insulin Glargine (Lantus) in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics. 11(5). 307–313. 4 indexed citations
7.
8.
Edgerton, Dale S., Alan D. Cherrington, Doss W. Neal, et al.. (2008). Inhaled Insulin Is Associated with Prolonged Enhancement of Glucose Disposal in Muscle and Liver in the Canine. Journal of Pharmacology and Experimental Therapeutics. 328(3). 970–975. 5 indexed citations
9.
Strack, Thomas. (2007). Imaging as a tool in drug development. Drugs of today. 43(10). 725–725. 4 indexed citations
10.
Edgerton, Dale S., Doss W. Neal, Melanie Scott, et al.. (2006). Inhalation of Human Insulin Is Associated with Improved Insulin Action Compared with Subcutaneous Injection and Endogenous Secretion in Dogs. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1258–1264. 7 indexed citations
11.
12.
Strack, Thomas. (2006). Inhaled human insulin. Drugs of today. 42(4). 207–207. 7 indexed citations
13.
Roach, Paris, et al.. (2001). IMPROVED GLYCAEMIC CONTROL WITH THE USE OF SELF‐PREPARED MIXTURES OF INSULIN LISPRO AND INSULIN LISPRO PROTAMINE SUSPENSION IN PATIENTS WITH TYPES 1 AND 2 DIABETES. International Journal of Clinical Practice. 55(3). 177–182. 22 indexed citations
14.
Ross, S., et al.. (2001). A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.. PubMed. 24(6). 292–8. 56 indexed citations
15.
Strack, Thomas. (1996). Alexander von Humboldts amerikanisches Reisewerk: Ethnographie und Kulturkritik um 1800. The German Quarterly. 69(3). 233–233.
16.
17.
Strack, Thomas, Gordon R. Greenberg, K. S. Polonsky, & A. M. Albisser. (1990). The effect of a time delay on the characteristics of the canine glucoregulatory system. Metabolism. 39(12). 1219–1224. 2 indexed citations
18.
Beyer, Jürgen, et al.. (1990). The influence of different generations of computer algorithms on diabetes control. Computer Methods and Programs in Biomedicine. 32(3-4). 225–232. 11 indexed citations
19.
Strack, Thomas, et al.. (1988). Compliance in microcomputer-assisted conventional insulin therapy: computer simulation study results. American Journal of Physiology-Endocrinology and Metabolism. 254(2). E237–E242. 4 indexed citations
20.
Strack, Thomas, et al.. (1984). Development of Individual Insulin Infusion Profiles for Open Loop Infusion Systems. Hormone and Metabolic Research. 16(4). 163–167. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hélène Dulude Breakdown of academic impact, for papers by Yuh‐Seog Jung Breakdown of academic impact, for papers by Öyvind Östraat Breakdown of academic impact, for papers by Alessandra Martorella Breakdown of academic impact, for papers by Nima Almassi Breakdown of academic impact, for papers by Jeff M. Holzbeierlein Breakdown of academic impact, for papers by H. J. de Voogt Breakdown of academic impact, for papers by Halil Kavgacı Breakdown of academic impact, for papers by David Paulson Breakdown of academic impact, for papers by Katsumi Taki
Rankless by CCL
2026